Literature DB >> 12621130

Aspirin and the prevention of colorectal cancer.

Thomas F Imperiale1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12621130     DOI： 10.1056/NEJMp030005

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.

Authors:  Raghib Ali; Han-Chong Toh; Whay-Kuang Chia
Journal:  Trials       Date:  2011-12-14       Impact factor: 2.279

2.  The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.

Authors:  Chung Yin Kong; Kevin J Nattinger; Tristan J Hayeck; Zehra B Omer; Y Claire Wang; Stuart J Spechler; Pamela M McMahon; G Scott Gazelle; Chin Hur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-19       Impact factor: 4.254

3.  [ASS in the prophylaxis of colorectal cancer].

Authors:  C Pox; W Schmiegel; S Nitschmann
Journal:  Internist (Berl)       Date:  2008-03       Impact factor: 0.743

4.  Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.

Authors:  S Sangha; M Yao; M M Wolfe
Journal:  Postgrad Med J       Date:  2005-04       Impact factor: 2.401

5.  Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme.

Authors:  Mazin A Al-Salihi; Scott C Ulmer; Thao Doan; Cory D Nelson; Tracy Crotty; Stephen M Prescott; Diana M Stafforini; Matthew K Topham
Journal:  Cell Signal       Date:  2007-05-23       Impact factor: 4.315

6.  Chemoprevention for colorectal neoplasia.

Authors:  Alyssa D Fajardo; Bruce W Robb
Journal:  Clin Colon Rectal Surg       Date:  2008-11

Review 7.  Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly.

Authors:  Peter R Holt; Peter Kozuch; Seetal Mewar
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

8.  Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.

Authors:  Nan Chiang; Edmund A Bermudez; Paul M Ridker; Shelley Hurwitz; Charles N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-07       Impact factor: 11.205

Review 9.  Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.

Authors:  Whay Kuang Chia; Raghib Ali; Han Chong Toh
Journal:  Nat Rev Clin Oncol       Date:  2012-08-21       Impact factor: 66.675

10.  Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression.

Authors:  Mazin A Al-Salihi; A Terrece Pearman; Thao Doan; Ethan C Reichert; Daniel W Rosenberg; Stephen M Prescott; Diana M Stafforini; Matthew K Topham
Journal:  Cancer Lett       Date:  2008-09-14       Impact factor: 8.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.